{"version":"1.0","provider_name":"Laos Alliance Pharmaceutical Group","provider_url":"https:\/\/alliancepharmagroup.com\/lo","title":"ALIUPATINIB - Laos Alliance Pharmaceutical Group","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"nwCKhXHUM1\"><a href=\"https:\/\/alliancepharmagroup.com\/lo\/\u0eaa\u0eb4\u0e99\u0e84\u0ec9\u0eb2\/aliupatinib\/\">ALIUPATINIB<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/alliancepharmagroup.com\/lo\/\u0eaa\u0eb4\u0e99\u0e84\u0ec9\u0eb2\/aliupatinib\/embed\/#?secret=nwCKhXHUM1\" width=\"600\" height=\"338\" title=\"&#8220;ALIUPATINIB&#8221; &#8212; Laos Alliance Pharmaceutical Group\" data-secret=\"nwCKhXHUM1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/alliancepharmagroup.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/alliancepharmagroup.com\/wp-content\/uploads\/2024\/12\/Aliupatinib.png","thumbnail_width":1280,"thumbnail_height":1280,"description":"COMPOSITION Upadacitinib....................................15mg INDICATION   Adults who have had an inadequate response or intolerance to one or more TNF blockers having the following conditions:   Moderate to severe active rheumatoid arthritis.  Active psoriatic arthritis.  Moderate to severe ulcerative colitis.  Moderate to severe Crohn\u2019s disease.  Active ankylosing spondylitis.  Active non-radiographic axial spondylarthritis.    Adults and pediatric patients 12 years of age and older with refractory, moderate to severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics, or when use of those therapies is inadvisable.  PACKAGING: 15 mg\/Tablet\uff1b28 Tablets\/box. Reg No: 11 L 1260\/24 Download ALIUPATINIB Drug Registration Certificate ... Read More"}